EnviroTech :: Catalysts and Licensing
SAFC Partners with Pfenex to Codevelop Biopharmaceuticals (update)
7:45 AM MDT | June 8, 2011 | Alex Scott
Pfenex (San Diego), a pioneer in protein expression systems, has entered into a non-exclusive partnership with Sigma-Aldrich Fine Chemicals (SAFC) for the manufacture of therapeutic recombinant proteins. Under the agreement, Pfenex will engineer production strains and processes for SAFC’s contract manufacturing customers. Additionally, the companies plan to work together to introduce conjugate vaccines. The project would combine Pfenex’s expertise in the manufacture of vaccine components with SAFC’s expertise and facilities for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee